Introduction: Abdominoperineal Resection (APR) remains an important option for patients with
advanced rectal cancer though some may require multivisceral resection (MVR) in addition to APR. We
hypothesized that oncological outcomes would be worse with MVR.
Methods: A retrospective review from 2006 to 2015 of 161 patients undergoing APR or MVR for rectal
cancer, of whom 118 underwent curative APR or APR with MVR. Perioperative, oncologic and survival
metrics were evaluated.
Results: There were 82 patients who underwent APR and 36 who underwent MVR. Surgical approach
and incidence of complications were similar (All P > 0.05). There was 1 local recurrence in each of the
APR and MVR groups at a mean follow-up of 34 and 32 months, respectively. Distant recurrences
occurred in 3 APR patients and 4 MVR patients.
Conclusions: APR and APR with MVR can be performed with comparable morbidity and oncologic
outcomes.
Summary
For patients with locally advanced or recurrent rectal cancers, abdominoperineal resection remains an
important option for curative resection, however some patients may require multivisceral resection in
addition to abdominoperineal resection. In our retrospective review of 118 patients who underwent
curative resection, we found comparable rates of short-term complications and survival outcomes between
patients undergoing abdominoperineal resection alone or in conjunction with a multivisceral
resection.